โญ 10/10 Life Sciences Learning • B10logy = 10 out of 10 in Biology • High-Yield Visual Notes Across 23 Disciplines Explore Subjects →

Immunology: Chapter 7 โ€” MHC and antigen presentation

Module 07 โ€ข Chapter Study Notes Part of ๐Ÿ›ก๏ธ Immunology

Chapter 7: MHC and antigen presentation

๐Ÿ“Œ Core Learning Outcomes

Contrast MHC class I with class II in structure, expression, peptide source, and T-cell partner. Explain polymorphism and the two processing pathways, including cross-presentation.

7.1 The molecules #

7.1.1 Two scaffolds, two T cells #

T-cell receptors do not bind free antigen. Zinkernagel and Doherty showed in 1974 that a T cell recognises antigen only together with self MHC: the receptor contacts peptide and the MHC protein holding it. Class I is a heavy chain plus ฮฒ2-microglobulin, which is encoded outside the MHC. The groove is closed, peptides are about 8โ€“10 residues with allele-specific anchors, and CD8 binds the ฮฑ3 domain. Nearly every nucleated cell expresses class I, so a CD8 cell can survey it. Class II is an ฮฑฮฒ dimer, both chains in the MHC, with an open groove and peptides often about 13โ€“25 residues. CD4 binds class II. Expression is limited to dendritic cells, macrophages, B cells, and thymic epithelium, and IFN-ฮณ can induce it elsewhere.

FeatureMHC class IMHC class II
Chainsฮฑ plus ฮฒ2-microglobulinฮฑ plus ฮฒ
PeptideClosed groove; about 8โ€“10 residuesOpen groove; often about 13โ€“25 residues
Expressed onNearly all nucleated cellsDendritic cells, macrophages, B cells, thymic epithelium
Peptide sourceCytosol, plus cross-presented antigenEndosomes and phagosomes
T cellCD8CD4
Classical HLA lociHLA-A, HLA-B, HLA-CHLA-DP, HLA-DQ, HLA-DR

7.1.2 Codominance, polymorphism, and why both matter #

Both haplotypes are expressed, so a heterozygote presents a wider set of peptides. The loci are the most polymorphic in the human genome, and the differences sit in the peptide-binding pockets: a peptide that fits one person’s HLA-A may be invisible to a neighbour. For a population that is a benefit, because a pathogen that escapes one set of grooves still meets others. Particular alleles also present disease-related peptides well, as with HLA-B27 in ankylosing spondylitis and HLA-DQ2 and HLA-DQ8 in coeliac disease. For transplantation the same polymorphism is the obstacle. The loci travel as a haplotype, so siblings have a one-in-four chance of sharing both.

7.1.3 Names #

The human MHC is HLA, on chromosome 6. Classical class I genes are HLA-A, HLA-B, and HLA-C. ฮฒ2-microglobulin is on chromosome 15. Class II genes are HLA-DP, HLA-DQ, and HLA-DR, and one DR haplotype often encodes an extra ฮฒ chain, hence two DR molecules.

7.2 Processing pathways #

The study of Processing pathways provides fundamental principles governing cellular architecture, molecular interactions, and physiological regulation.

๐Ÿ”ฌ Key Illustrated Scientific Figure
Il-18 Signaling Pathway (Homo Sapiens)
Click to enlarge on this page

Il-18 Signaling Pathway (Homo Sapiens)

Interpretation & Mechanism: Interleukin-18 (IL-18) is a member of the IL-1 family of cytokines and was initially described as an IFN-รŽยณ-inducing factor derived from anti-CD3-stimulated T-helper (Th)1 cells. IL-18 plays a significant role in the activation of hematopoietic cell types mediating both Th1 and Th2 responses and is the primary inducer of interferon-รŽยณ in these cells. The biological activity of IL-18 is mediated through its binding to the IL-18 receptor complex and activation of nuclear factor-รŽยบB (NF-รŽยบB), culminating in the production and release of several cytokines, chemokines, and cellular adhesion molecules. In certain cell types, IL-18 also activates mitogen-activated protein kinases (MAPKs) and phosphoinositide 3-kinase/ AKT serine/threonine kinase (PI3K/AKT) signaling modules leading to the production and release of proinflammatory cytokines. IL-18-mediated signaling acts as one of the vital components of the immunomodulatory cytokine networks involved in host defense, inflammation, and tissue regeneration. Albeit its biomedical importance, a comprehensive resource of IL-18 mediated signaling pathway is currently lacking. In this study, we report on the development of an integrated pathway map of IL-18/IL-18R signaling. The pathway map was developed through literature mining from published literature based on manual curation guidelines adapted from NetPath and includes information on 16 protein-protein interaction events, 38 enzyme-catalysis events, 12 protein translocation events, 26 activations/inhibition events, transcriptional regulators, 230 gene regulation events and 84 induced protein expression events.

7.2.1 The cytosolic route to MHC class I #

Class I reports on the cytosol. Ubiquitinated proteins are degraded by the proteasome; IFN-ฮณ induces alternative subunits, including LMP2 and LMP7 in the MHC, that favour peptides suited to class I. TAP1 and TAP2 pump those peptides into the endoplasmic reticulum. A loading complex that includes tapasin holds empty class I until a suitable peptide completes folding with ฮฒ2-microglobulin, and the complex travels the secretory pathway. Empty class I is unstable. Loss of TAP or tapasin leaves little surface class I and few CD8 cells.

7.2.2 The endosomal route to MHC class II #

Class II reports on material taken up from outside, including antigen internalised by a B-cell receptor. The dimer assembles with invariant chain (CD74), which fills the groove so class I peptides cannot bind and targets the complex to a late endosome. Proteases degrade the invariant chain to CLIP. HLA-DM catalyses CLIP release and loading of a stable endosomal peptide. Mature dendritic cells then slow further exchange, so they keep displaying the peptides captured at the moment they were activated.

7.2.3 Cross-presentation #

An epithelial cell infected by a virus can be killed by an effector CD8 cell, but it cannot prime a naive one: it supplies neither costimulation nor traffic into the paracortex. Dendritic cells prime by placing antigen they acquired from outside onto their own class I. That is cross-presentation, done best by the cDC1 subset, either by feeding protein into the cytosol for proteasome and TAP or by loading class I inside a vesicle. The result is a CD8 response against a virus the dendritic cell never let replicate, and against tumour debris.

7.3 Key terms, summary, and self-check #

Key terms. MHC restriction; ฮฒ2-microglobulin; codominance; polymorphism; haplotype; HLA-A; HLA-B; HLA-C; HLA-DP; HLA-DQ; HLA-DR; TAP; tapasin; invariant chain; CLIP; HLA-DM; cross-presentation.

Summary. Class I on nearly all nucleated cells presents short cytosolic peptides to CD8 cells. Class II on professional antigen-presenting cells presents longer endosomal peptides to CD4 cells. Both haplotypes are expressed, and polymorphic grooves slow pathogen escape in a population and cause graft rejection between people. Cytosolic proteins reach class I through the proteasome and TAP. Endosomal proteins reach class II after HLA-DM exchanges CLIP for peptide. Cross-presentation lets dendritic cells prime CD8 cells against antigen they did not synthesise.

Self-check.

1. Compare class I and class II on peptide length, expressing cells, and T-cell partner.

2. Why does MHC polymorphism help a population and hinder a transplant?

3. What does TAP transport, and what is CLIP doing in the class II groove?

4. What does HLA-DM do that invariant chain does not?

5. What failure of priming follows if dendritic cells cannot cross-present?

Back to Immunology โšก One Night Revision → Explore All Disciplines